ValorQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26TTMGastos comerciales, generales y administrativos1.49 B1.47 B1.6 B1.67 B1.75 B1.8 B6.82 BInvestigación y desarrollo———————Beneficio operativo126.64 M706.25 M1.04 B867.65 M18.5 M760.45 M2.68 BTotal de ingresos no operativos19.51 M-57.87 M-3.55 M110.42 M-127.71 M20.6 M-243 KGastos por intereses, netos de intereses capitalizados———————Ingresos no operativos, una vez deducidos los gastos por intereses19.51 M-57.87 M-3.55 M110.42 M-127.71 M20.6 M-243 KIngresos/gastos extraordinarios———————Beneficio antes de impuestos125.18 M620.45 M928.66 M896.28 M-187.04 M708.64 M2.35 BParticipación en los beneficios———————Impuestos117.71 M126.73 M211.24 M206.53 M146.03 M142.51 M706.31 MParticipación minoritaria4.08 M5.12 M-454 K2.35 M6.63 M6.48 M15.01 MOtros ingresos/gastos después de impuestos-8.31 M-7.05 M-2.77 M39.77 M3.59 M-6.73 M33.87 MBeneficio neto antes de actividades interrumpidas3.38 M488.6 M717.87 M687.4 M-339.7 M559.65 M1.63 BOperaciones suspendidas———————Beneficio neto3.38 M488.6 M717.87 M687.4 M-339.7 M559.65 M1.63 BAjuste por dilución———————Dividendos de las acciones preferentes———————Beneficio neto diluido atribuible a los accionistas3.38 M488.6 M717.87 M687.4 M-339.7 M559.65 M1.63 BBeneficio básico por acción0.042.523.73.55-1.752.888.38Beneficio por acción diluido0.042.53.683.52-1.742.878.33Número medio de acciones ordinarias198.5 M193.76 M193.8 M193.82 M193.82 M194.22 M775.66 MAcciones diluidas200.28 M195.19 M195.09 M195.23 M195.21 M195.32 M780.86 MEBITDA-125.22 M987.98 M1.5 B1.12 B-285.54 M1.4 B3.74 BEBIT-404.97 M706.51 M1.24 B861.97 M-549.54 M1.14 B2.69 BCosto de los ingresos76.56 B78.93 B72.39 B77.76 B80.77 B82.86 B313.79 BOtros costes de producción———————Amortización y depreciación (flujo de caja)279.75 M281.47 M263.97 M258.97 M264 M260.4 M1.05 B
Cencora Inc
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment.